vs
Side-by-side financial comparison of FIRST FINANCIAL CORP (THFF) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Twist Bioscience Corp is the larger business by last-quarter revenue ($103.7M vs $70.5M, roughly 1.5× FIRST FINANCIAL CORP). FIRST FINANCIAL CORP runs the higher net margin — 30.4% vs -29.4%, a 59.8% gap on every dollar of revenue. On growth, Twist Bioscience Corp posted the faster year-over-year revenue change (16.9% vs 14.1%). FIRST FINANCIAL CORP produced more free cash flow last quarter ($86.4M vs $-34.8M).
First American Financial Corporation is an American financial services company which provides title insurance and settlement services to the real estate and mortgage industries.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
THFF vs TWST — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $70.5M | $103.7M |
| Net Profit | $21.5M | $-30.5M |
| Gross Margin | — | 52.0% |
| Operating Margin | 37.4% | -31.7% |
| Net Margin | 30.4% | -29.4% |
| Revenue YoY | 14.1% | 16.9% |
| Net Profit YoY | 32.1% | 3.4% |
| EPS (diluted) | $1.81 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.5M | $103.7M | ||
| Q3 25 | $65.8M | — | ||
| Q2 25 | $63.1M | — | ||
| Q1 25 | $62.5M | — | ||
| Q4 24 | $61.8M | — | ||
| Q3 24 | $58.4M | — | ||
| Q2 24 | $49.2M | — | ||
| Q1 24 | $48.4M | — |
| Q4 25 | $21.5M | $-30.5M | ||
| Q3 25 | $20.8M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $18.4M | — | ||
| Q4 24 | $16.2M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $11.4M | — | ||
| Q1 24 | $10.9M | — |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 37.4% | -31.7% | ||
| Q3 25 | 39.2% | — | ||
| Q2 25 | 36.2% | — | ||
| Q1 25 | 38.1% | — | ||
| Q4 24 | 32.4% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 27.6% | — | ||
| Q1 24 | 27.2% | — |
| Q4 25 | 30.4% | -29.4% | ||
| Q3 25 | 31.6% | — | ||
| Q2 25 | 29.5% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 23.1% | — | ||
| Q1 24 | 22.6% | — |
| Q4 25 | $1.81 | $-0.50 | ||
| Q3 25 | $1.75 | — | ||
| Q2 25 | $1.57 | — | ||
| Q1 25 | $1.55 | — | ||
| Q4 24 | $1.37 | — | ||
| Q3 24 | $0.74 | — | ||
| Q2 24 | $0.96 | — | ||
| Q1 24 | $0.93 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $197.9M |
| Total DebtLower is stronger | $188.2M | — |
| Stockholders' EquityBook value | $650.9M | $456.1M |
| Total Assets | $5.8B | $638.1M |
| Debt / EquityLower = less leverage | 0.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $197.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $188.2M | — | ||
| Q3 25 | $170.5M | — | ||
| Q2 25 | $122.7M | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $28.1M | — | ||
| Q3 24 | $30.5M | — | ||
| Q2 24 | $108.6M | — | ||
| Q1 24 | $58.6M | — |
| Q4 25 | $650.9M | $456.1M | ||
| Q3 25 | $622.2M | — | ||
| Q2 25 | $587.7M | — | ||
| Q1 25 | $571.9M | — | ||
| Q4 24 | $549.0M | — | ||
| Q3 24 | $566.0M | — | ||
| Q2 24 | $530.7M | — | ||
| Q1 24 | $520.8M | — |
| Q4 25 | $5.8B | $638.1M | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $5.6B | — | ||
| Q1 25 | $5.5B | — | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $5.5B | — | ||
| Q2 24 | $4.9B | — | ||
| Q1 24 | $4.9B | — |
| Q4 25 | 0.29× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.21× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $90.4M | $-24.8M |
| Free Cash FlowOCF − Capex | $86.4M | $-34.8M |
| FCF MarginFCF / Revenue | 122.5% | -33.5% |
| Capex IntensityCapex / Revenue | 5.6% | 9.6% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $144.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.4M | $-24.8M | ||
| Q3 25 | $26.9M | — | ||
| Q2 25 | $12.7M | — | ||
| Q1 25 | $21.1M | — | ||
| Q4 24 | $60.4M | — | ||
| Q3 24 | $23.3M | — | ||
| Q2 24 | $8.8M | — | ||
| Q1 24 | $12.4M | — |
| Q4 25 | $86.4M | $-34.8M | ||
| Q3 25 | $25.8M | — | ||
| Q2 25 | $11.6M | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | $54.3M | — | ||
| Q3 24 | $19.5M | — | ||
| Q2 24 | $8.4M | — | ||
| Q1 24 | $11.5M | — |
| Q4 25 | 122.5% | -33.5% | ||
| Q3 25 | 39.2% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 87.8% | — | ||
| Q3 24 | 33.5% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | 23.7% | — |
| Q4 25 | 5.6% | 9.6% | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 6.5% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 2.0% | — |
| Q4 25 | 4.21× | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | 0.68× | — | ||
| Q1 25 | 1.14× | — | ||
| Q4 24 | 3.72× | — | ||
| Q3 24 | 2.67× | — | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.14× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
THFF
Segment breakdown not available.
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
